Multiple Sclerosis: Advances in Research and Treatment
Links shared publicly online about this topic.
- 1,171total visits
Multiple Sclerosis: Advances in Research and Treatment
View full resource at webmd.com
Tags: Multiple Sclerosis, Disease and Condition
Most Recently Shared on May 13, 2010 at 10:56 pm By:
Multiple Sclerosis: Advances in Research and Treatment: While the cause of multiple sclerosis or MS is still not k... http://bit.ly/9lIftH
Also Shared By:
Minimally invasive endovascular treatment for CCSVI is safe in patients with MS
news-medical.net — “Researchers who investigated the connection between chronic cerebrospinal venous insufficiency (a reported condition characterized as a blockage in the veins that drain blood from the brain and spinal cord and returns it to the heart) and multiple sclerosis indicate that a minimally invasive endovascular treatment for CCSVI, is safe and may produce "significant," short-term improvement in physical- and mental health-related quality of life in individuals with MS.” View full resource at news-medical.net
Most Recently Shared on March 26, 2012 at 11:07 am By:
News-Medical.Net Health News and Oncology
Oncology News: Minimally invasive endovascular treatment for CCSVI is safe in patients with MS: Researchers who ... http://t.co/Hngqu5wX
Mitigating Symptoms, Improving Quality Of Life Of Multiple Sclerosis Patients
medicalnewstoday.com — “Researchers report that performing angioplasty (a treatment that involves temporarily inserting and blowing up a tiny balloon inside a clogged artery to help widen it) on veins in the neck and ch” View full resource at medicalnewstoday.com
Most Recently Shared on March 26, 2012 at 8:05 am By:
Mitigating Symptoms, Improving Quality Of Life Of Multiple Sclerosis Patients http://t.co/2ZSMzEVG #multiplesclerosis
Interventional radiology: Mitigating symptoms, improving quality of life of MS patients
eurekalert.org — “Researchers report that performing angioplasty (a treatment that involves temporarily inserting and blowing up a tiny balloon inside a clogged artery to help widen it) on veins in the neck and chest is safe -- and may be an effective way to treat the venous abnormalities found in those with multiple sclerosis and provide symptom relief.” View full resource at eurekalert.org
Most Recently Shared on March 26, 2012 at 2:39 am By:
Interventional radiology: Mitigating symptoms, improving quality of life of MS patients: (Society of Interventio... http://t.co/yqden9sX
Interventional radiologists see 'significant' symptom relief in MS patients
eurekalert.org — “Researchers who investigated the connection between chronic cerebrospinal venous insufficiency (a reported condition characterized as a blockage in the veins that drain blood from the brain and spinal cord and returns it to the heart) and multiple sclerosis indicate that a minimally invasive endovascular treatment for CCSVI, is safe and may produce "significant," short-term improvement in physical- and mental health-related quality of life in individuals with MS.” View full resource at eurekalert.org
Most Recently Shared on March 26, 2012 at 2:39 am By:
Interventional radiologists see 'significant' symptom relief in MS patients: (Society of Interventional Radiolog... http://t.co/ncjKkuI9
Laquinimod trial results published | News | MS Trust - Information, education, research and support
mstrust.org.uk — “Latest news about multiple sclerosis from the MS Trust” View full resource at mstrust.org.uk
Most Recently Shared on March 16, 2012 at 1:08 am By:
Laquinimod trial results published: Laquinimod, a potential oral treatment for relapsing remitting MS, has a mod... http://t.co/tc27FE3B
Research Scientists Create Molecular Map To Guide Treatment Of Multiple Sclerosis
medicalnewstoday.com — “A team of scientists from the Scripps Research Institute, collaborating with members of the drug discovery company Receptos, has created the first high-resolution virtual image of cellular structu” View full resource at medicalnewstoday.com
Most Recently Shared on February 19, 2012 at 8:05 am By:
Research Scientists Create Molecular Map To Guide Treatment Of Multiple Sclerosis: A team of scientists from the... http://t.co/M5OqCqff
NIH Common Fund researchers uncover structure of important target for drug design, February 16, 2012 News Release - National Institutes of Health (NIH)
nih.gov — “Researchers have uncovered a potent class of small molecules that selectively turn on the S1P1 receptor, a type of receptor in cells that can be targeted in the design of new treatments for diseases such as multiple sclerosis. These findings are reported in the Feb. 17 issue of the journal Science. The research was supported by the National Institutes of Health Common Fund and the National Institute of General Medical Science (NIGMS).” View full resource at nih.gov
Most Recently Shared on February 16, 2012 at 7:34 pm By:
News: NIH Common Fund researchers uncover structure of important target for drug design http://t.co/AL3ofwMv
Research demonstrating link between virus and MS could point the way to treatment and prevention
sciencedaily.com — “A new study from researchers at Queen Mary, University of London shows how a particular virus tricks the immune system into triggering inflammation and nerve cell damage in the brain, which is known to cause MS.” View full resource at sciencedaily.com
Most Recently Shared on January 7, 2012 at 4:27 pm By:
Multiple Sclerosis Sees Explosion in Treatment Advances - ABC News
abcnews.go.com — “The past decade has offered greatest advances in multiple sclerosis that it may be difficult to believe that at one time, the chances of successfully combating the condition were slim.” View full resource at abcnews.go.com
Most Recently Shared on January 5, 2012 at 4:04 pm By:
Tune in tonight to @ABC World News with Diane Sawyer: a segment on encouraging developments in #MS treatments. http://t.co/BzqOHFv6
MTR technique indicates that COPAXONE therapy results in tissue repair in RRMS patients
news-medical.net — “Researchers utilizing an advanced magnetic resonance imaging (MRI) technology to characterize and chart the evolution of MS lesions found that relapsing-remitting multiple sclerosis (RRMS) patients treated with COPAXONE (glatiramer acetate injection) experienced significantly increased magnetization transfer ratio.” View full resource at news-medical.net
Most Recently Shared on January 4, 2012 at 2:19 pm By:
News-Medical.Net Health News and Oncology
Oncology News: MTR technique indicates that COPAXONE therapy results in tissue repair in RRMS patients: Research... http://t.co/5nsQ0ex9
From the Front Lines: MS Research to Follow in 2012 - Yahoo! News
news.yahoo.com — “From Yahoo! News: National MS Society Live Webcast December 13 Will Offer MS News You Can Use From Internationally Renowned ResearchersNew York, NY (PRWEB) December 08, 2011 This year saw exciting research progress in efforts to stop multiple sclerosis, restore function that’s been lost and end the disease entirely. At least three emerging therapies are advancing through the pipeline toward FDA review while at least four clinical trials focusing on progressive MS continue to move forward. ...” View full resource at news.yahoo.com
Most Recently Shared on December 8, 2011 at 6:32 pm By:
Urology & Nephrology OW Health
From the Front Lines: MS Research to Follow in 2012: National MS Society Live Webcast December 13 Will Offer MS ... http://t.co/djKi2Zz0
Are Probiotics In Charge of Your Health?
articles.mercola.com — “Probiotics in your gut not only improve your digestive health, but also help you avoid multiple sclerosis and other health conditions.” View full resource at articles.mercola.com
Most Recently Shared on December 5, 2011 at 6:15 am By:
If You're Tired or Constipated, This "Unusual Treatment" May Help: By Dr. Mercola Research indicates that suppl... http://t.co/1Q3S5Tnj
New treatment for Multiple Sclerosis: Cambridge University translates research at the bench into a drug at the bedside
medicalxpress.com — “The culmination of three decades of research in Cambridge has resulted in the exciting prospect of a new transformational treatment for multiple sclerosis.” View full resource at medicalxpress.com
Most Recently Shared on November 15, 2011 at 4:43 pm By:
New treatment for Multiple Sclerosis: Cambridge University translates research at the bench into a drug at the b... http://t.co/HHDse4dk
Adeona And The Skirball Foundation Join Forces To Advance Multiple Sclerosis Research
medicalnewstoday.com — “Adeona Pharmaceuticals, Inc. (NYSE Amex: AEN), a developer of innovative medicines for serious central nervous system diseases, announced that the Company's drug candidate, Trimesta™ (oral e” View full resource at medicalnewstoday.com
Most Recently Shared on November 12, 2011 at 9:05 am By:
Adeona And The Skirball Foundation Join Forces To Advance Multiple Sclerosis Research http://t.co/01GxaqXX #multiplesclerosis
Medical News: MS Markers Match Disability Progression - in Clinical Context, Multiple Sclerosis from MedPage Today
medpagetoday.com — “Two surrogate markers commonly used in multiple sclerosis clinical trials are near-perfect measures of the effect of treatment with interferon, researchers reported.” View full resource at medpagetoday.com
Most Recently Shared on November 3, 2011 at 8:38 pm By:
Patricia Grace Eldercare Expert
MS Markers Match Disability Progression (CME/CE): (MedPage Today) -- Two surrogate markers commonly used in mult... http://t.co/yjYBCgid
Advertisement
Heart Health
@HeartsHealth
webMD: Multiple Sclerosis: Advances in Research and Treatment http://bit.ly/bxf8fr Full http://bit.ly/d0kLlZ
1 year ago...